Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney Fibrosis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney Fibrosis Treatmentmarket, defines the market attractiveness level of Kidney Fibrosis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney Fibrosis Treatment industry, describes the types of Kidney Fibrosis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney Fibrosis Treatment market and the development prospects and opportunities of Kidney Fibrosis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney Fibrosis Treatment market in Chapter 13.
By Player:
Genzyme Corporation (US)
Pfizer Inc (US)
Merck & Co (US)
F Hoffman-La Roche (Switzerland)
InterMune Inc (US)
ProMetic Life-Sciences Inc (Canada)
Galectin Therapeutics (US)
La Jolla Pharmaceutical Company (US)
BioLine Rx (Israel)
By Type:
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
By End-User:
Chronic Kidney Diseases
Kidney Cancer Treatment
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney Fibrosis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney Fibrosis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney Fibrosis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney Fibrosis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney Fibrosis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.2 United States Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.3 Europe Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.4 China Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.5 Japan Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.6 India Kidney Fibrosis Treatment Consumption (2017-2022)
-
7.7 South Korea Kidney Fibrosis Treatment Consumption (2017-2022)
8 Region and Country-wise Kidney Fibrosis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.4 China Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.6 India Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney Fibrosis Treatment Consumption Forecast (2022-2028)
9 Global Kidney Fibrosis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Fibrosis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Fibrosis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Kidney Cancer Treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Kidney Fibrosis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney Fibrosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney Fibrosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Kidney Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney Fibrosis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney Fibrosis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney Fibrosis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney Fibrosis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney Fibrosis Treatment Market Competitive Analysis
-
14.1 Genzyme Corporation (US)
-
14.1.1 Genzyme Corporation (US) Company Details
-
14.1.2 Genzyme Corporation (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genzyme Corporation (US) Kidney Fibrosis Treatment Product and Service
-
14.2 Pfizer Inc (US)
-
14.2.1 Pfizer Inc (US) Company Details
-
14.2.2 Pfizer Inc (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Inc (US) Kidney Fibrosis Treatment Product and Service
-
14.3 Merck & Co (US)
-
14.3.1 Merck & Co (US) Company Details
-
14.3.2 Merck & Co (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co (US) Kidney Fibrosis Treatment Product and Service
-
14.4 F Hoffman-La Roche (Switzerland)
-
14.4.1 F Hoffman-La Roche (Switzerland) Company Details
-
14.4.2 F Hoffman-La Roche (Switzerland) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffman-La Roche (Switzerland) Kidney Fibrosis Treatment Product and Service
-
14.5 InterMune Inc (US)
-
14.5.1 InterMune Inc (US) Company Details
-
14.5.2 InterMune Inc (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 InterMune Inc (US) Kidney Fibrosis Treatment Product and Service
-
14.6 ProMetic Life-Sciences Inc (Canada)
-
14.6.1 ProMetic Life-Sciences Inc (Canada) Company Details
-
14.6.2 ProMetic Life-Sciences Inc (Canada) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ProMetic Life-Sciences Inc (Canada) Kidney Fibrosis Treatment Product and Service
-
14.7 Galectin Therapeutics (US)
-
14.7.1 Galectin Therapeutics (US) Company Details
-
14.7.2 Galectin Therapeutics (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Galectin Therapeutics (US) Kidney Fibrosis Treatment Product and Service
-
14.8 La Jolla Pharmaceutical Company (US)
-
14.8.1 La Jolla Pharmaceutical Company (US) Company Details
-
14.8.2 La Jolla Pharmaceutical Company (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 La Jolla Pharmaceutical Company (US) Kidney Fibrosis Treatment Product and Service
-
14.9 BioLine Rx (Israel)
-
14.9.1 BioLine Rx (Israel) Company Details
-
14.9.2 BioLine Rx (Israel) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BioLine Rx (Israel) Kidney Fibrosis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney Fibrosis Treatment
-
Figure Kidney Fibrosis Treatment Picture
-
Table Global Kidney Fibrosis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Fibrosis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Fibrosis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney Fibrosis Treatment Consumption by Country (2017-2022)
-
Figure United States Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Fibrosis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
Figure Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney Fibrosis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney Fibrosis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Genzyme Corporation (US) (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation (US) Kidney Fibrosis Treatment Product and Service
-
Table Pfizer Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc (US) Kidney Fibrosis Treatment Product and Service
-
Table Merck & Co (US) (Foundation Year, Company Profile and etc.)
-
Table Merck & Co (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co (US) Kidney Fibrosis Treatment Product and Service
-
Table F Hoffman-La Roche (Switzerland) (Foundation Year, Company Profile and etc.)
-
Table F Hoffman-La Roche (Switzerland) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman-La Roche (Switzerland) Kidney Fibrosis Treatment Product and Service
-
Table InterMune Inc (US) (Foundation Year, Company Profile and etc.)
-
Table InterMune Inc (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table InterMune Inc (US) Kidney Fibrosis Treatment Product and Service
-
Table ProMetic Life-Sciences Inc (Canada) (Foundation Year, Company Profile and etc.)
-
Table ProMetic Life-Sciences Inc (Canada) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProMetic Life-Sciences Inc (Canada) Kidney Fibrosis Treatment Product and Service
-
Table Galectin Therapeutics (US) (Foundation Year, Company Profile and etc.)
-
Table Galectin Therapeutics (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galectin Therapeutics (US) Kidney Fibrosis Treatment Product and Service
-
Table La Jolla Pharmaceutical Company (US) (Foundation Year, Company Profile and etc.)
-
Table La Jolla Pharmaceutical Company (US) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table La Jolla Pharmaceutical Company (US) Kidney Fibrosis Treatment Product and Service
-
Table BioLine Rx (Israel) (Foundation Year, Company Profile and etc.)
-
Table BioLine Rx (Israel) Kidney Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLine Rx (Israel) Kidney Fibrosis Treatment Product and Service
-
